The immune-related symptom web in immune checkpoint inhibitor therapy: a longitudinal clinical safety surveillance framework for immune-related adverse events.

Li B, Che H, Song Y

Open source

DOI
10.3389/fphar.2026.1942034
Published
2026
Container
Frontiers in pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1942034,
  title = {The immune-related symptom web in immune checkpoint inhibitor therapy: a longitudinal clinical safety surveillance framework for immune-related adverse events.},
  author = {Li B and Che H and Song Y},
  year = {2026},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2026.1942034},
  url = {https://doi.org/10.3389/fphar.2026.1942034}
}

RIS

TY  - JOUR
TI  - The immune-related symptom web in immune checkpoint inhibitor therapy: a longitudinal clinical safety surveillance framework for immune-related adverse events.
AU  - Li B
AU  - Che H
AU  - Song Y
PY  - 2026
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2026.1942034
UR  - https://doi.org/10.3389/fphar.2026.1942034
ER  - 

APA

B, L., H, C., & Y, S. (2026). The immune-related symptom web in immune checkpoint inhibitor therapy: a longitudinal clinical safety surveillance framework for immune-related adverse events.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2026.1942034

Source records